Amivas Bests La Jolla In Race For US Approval Of Antimalarial Artesunate

 
• By Sue Sutter
  
Wrench.
US FDA approval of Amivas’ artesunate has thrown a wrench in La Jolla’s plans to come to market with the same drug • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip